Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by Kowa Company, Ltd.
Sponsor:
Information provided by (Responsible Party):
Kowa Company, Ltd.
ClinicalTrials.gov Identifier:
NCT01640808
First received: July 10, 2012
Last updated: February 12, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)